FDMT: 4D Molecular Therapeutics Inc
FDMT exchange rate has changed by -1.85% for today. During the day, the instrument was traded at a low of 8.2250 and at a high of 8.6800.
Follow 4D Molecular Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
FDMT News
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:FDMT) 2026-01-19
- RBC Capital reiterates Outperform rating on 4D Molecular stock at $32
- Ashoo Gupta of 4D Molecular Therapeutics sells $3.3k in FDMT stock
- 4D Molecular Therapeutics: Jury Still Out On CF Gene Therapy After Dense Data Drop (NASDAQ:FDMT)
- BlackBerry, FedEx, Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Aimei Health Technology (NASDAQ:AFJK), Aura Biosciences (NASDAQ:AURA)
- Avago and Oracle among market cap stock movers on Wednesday
- 4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential Transcript
- 4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential - Slideshow (NASDAQ:FDMT) 2025-12-17
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies London Healthcare Conference 2025 Transcript
- 4d Molecular Therapeutics chief legal officer sells $17k in stock
- 4D Molecular Therapeutics appoints Kristian Humer as chief financial officer
- 4D Molecular Therapeutics stock price target raised by RBC to $32 on funding
- 4D Molecular earnings matched, revenue fell short of estimates
- 4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates
- 4D Molecular stock rating upgraded by Morgan Stanley on positive trial data
- 4D Molecular Therapeutics stock price target raised by Leerink Partners
Frequently Asked Questions
What is FDMT stock price today?
4D Molecular Therapeutics Inc stock is priced at 8.4800 today. It trades within 8.2250 - 8.6800, yesterday's close was 8.6400, and trading volume reached 1184. The live price chart of FDMT shows these updates.
Does 4D Molecular Therapeutics Inc stock pay dividends?
4D Molecular Therapeutics Inc is currently valued at 8.4800. Dividend policy depends on the company, while investors also watch -24.96% and USD. View the chart live to track FDMT movements.
How to buy FDMT stock?
You can buy 4D Molecular Therapeutics Inc shares at the current price of 8.4800. Orders are usually placed near 8.4800 or 8.4830, while 1184 and 1.56% show market activity. Follow FDMT updates on the live chart today.
How to invest into FDMT stock?
Investing in 4D Molecular Therapeutics Inc involves considering the yearly range 6.9600 - 12.3400 and current price 8.4800. Many compare -8.24% and -24.96% before placing orders at 8.4800 or 8.4830. Explore the FDMT price chart live with daily changes.
What are 4D Molecular Therapeutics Inc stock highest prices?
The highest price of 4D Molecular Therapeutics Inc in the past year was 12.3400. Within 6.9600 - 12.3400, the stock fluctuated notably, and comparing with 8.6400 helps spot resistance levels. Track 4D Molecular Therapeutics Inc performance using the live chart.
What are 4D Molecular Therapeutics Inc stock lowest prices?
The lowest price of 4D Molecular Therapeutics Inc (FDMT) over the year was 6.9600. Comparing it with the current 8.4800 and 6.9600 - 12.3400 shows potential long-term entry points. Watch FDMT moves on the chart live for more details.
When did FDMT stock split?
4D Molecular Therapeutics Inc has gone through stock splits historically. These changes are visible in , 8.6400, and -24.96% after corporate actions.
- Previous Close
- 8.6400
- Open
- 8.3500
- Bid
- 8.4800
- Ask
- 8.4830
- Low
- 8.2250
- High
- 8.6800
- Volume
- 1.184 K
- Daily Change
- -1.85%
- Month Change
- -8.24%
- 6 Months Change
- -24.96%
- Year Change
- -24.96%